ABSTRACT
INTRODUCTION
The impaired quality of life (QOL) and diminished work and classroom productivity of individuals with pruritic skin diseases is a matter of public concern. 1, 2 Furthermore, estimates of the impact of pruritic skin diseases on the economic loss in businesses and school performance records have attracted a great deal of interest worldwide. 3, 4 Similar unfavorable impacts were identified for certain skin diseases, such as chronic idiopathic urticaria, psoriasis, and chronic hand dermatitis. [5] [6] [7] [8] The Work Productivity Assessment Index (WPAI) is commonly used to determine the impact of health and disease on certain parameters related to patient productivity. According to the WPAI, the estimated percent of overall work impairment due to psoriasis, urticaria, and chronic hand dermatitis is 15%, 25%, and 29%, respectively. 5, 6, 8 Itching is a key characteristic of allergic skin diseases that dramatically affects a patient's quality of life. 9, 10 Thus, it is possible that itching alone would affect patient performance in the work place. The allergy specific WPAI (WPAI-AS) can be used to more effectively assess productivity in these patients as itching is a common symptom of allergy-related skin diseases. Recently, we reported the effect of antihistamines on productivity of patients with pruritic skin diseases using the WPAI-AS assessment questionnaire. 11, 12 On average, pruritic skin diseases impaired overall workplace productivity, classroom productivity, and daily activity by 39%, 45%, and 42% at baseline, respectively. 12 Furthermore, non-sedative antihistamines (mainly fexofenadine) reduced the intensity of itch and improved work productivity. In contrast, sedative antihistamines failed to improve work productivity, but significantly decreased itch intensity. 12 However, the relative impact of different pruritic diseases on work productivity has not been assessed. In this report, the WPAI-AS evaluation system was applied to each subgroup of patients with different diagnoses of pruritic skin diseases, and the degree of impairment for each disease at baseline was compared using a linear least-squares method. Furthermore, itch severity and patient QOL were assessed using a visual analogue scale (VAS) and Skindex-16, respectively. Finally, after validating the relationships between these parameters, we propose a method to approach the treatment of pruritic skin disease that will improve overall productivity in the workplace, in the classroom, and in daily activities.
METHODS

PATIENTS AND STUDY DESIGN
This study was conducted between April, 2008 and March, 2009. After obtaining approval from the Institutional Review Board (IRB), patients with pruritic skin diseases (n = 216) from Osaka University Hospital or its affiliated hospitals, gave informed consent to participate in this study. The final number of valid responses was n = 206 (male : female=93 : 113; mean age ± SD: 52 ± 20 years). Patients with skin diseases associated with underlying systemic diseases (e.g., serious liver disease, renal dysfunction, and blood diseases), history of epilepsy, history of a previous drug allergy, or women who were pregnant or lactating were excluded from this study. Participants received no medical attention during the week before study initiation. The selection of therapy for each patient, such as oral antihistamines versus external medicine (e.g., steroid ointments, tacrolimus ointments, or certain moisturizers), was left to the physician's discretion (open-label trial). Fexofenadine (n = 72) and loratadine (n = 2), anti-histamines for which the package insert contained no cautionary statement regarding sedative actions, were categorized as "nonsedative". All other antihistamines were classified as "sedative".
STUDY INSTRUMENTS
The Skindex-16 quality-of-life instrument 13 was used to measure the effect of pruritic skin diseases on QOL. The magnitude of the itch sensation was assessed using a VAS (0-100, "0" indicates no-symptom, and "100" indicates most severe symptom). Work and classroom productivity were assessed with the WPAI-AS instrument (score range, 0-100%; higher percentages indicate higher productivity). 11 Work productivity, classroom productivity, and daily activity impairment (%I) were calculated by the effects of the pruritic skin diseases on productivity while working! attending class or other daily activities during the past 7 days. The percentage of work! classroom time missed (%TM = TM! TW) was calculated by the number of work! classroom hours missed due to allergy (TM) and the usual number of hours worked! attending class (TW). Finally, the percentage overall impairment was calculated as follows: %TM + ( [100 -%TM] × I%) = % overall impairment. 11 These instruments were patient-administered before (baseline) and 1 month after treatment initiation.
STATISTICAL ANALYSIS
The one-sample t-test was used for analysis of differences between two groups. Pearson's productmoment correlation coefficient was used to determine the significance of correlations between two parameters (Table 1, 2) . To examine the significance of the contingency between the certain categorical data, Fisher's exact test (for evaluating the significance between the two kinds of classifications) and CochranMantel-Haenszel general association statistics (for evaluating more than 3 kinds of classifications) were performed ( Table 3 ). The bias of evaluative consequences to one variable was analyzed using univariate analysis (Table 4) . A linear least-squares method was used to evaluate the degree of impairment in each disease at baseline. Because heterogeneity of starting values was inevitable, the effect measures illustrated in Figure 1 were evaluated using linear models. The results and confidence intervals for the improvement variations were compared visually for each parameter using a forest plot. Improvement variations (change ratios) were calculated as follows: change ratio = (evaluated value 1 month after the initiation of treatment-baseline value)! (baseline value). In all tests, values of P < 0.05 were considered statistically significant.
RESULTS
STUDY POPULATION CHARACTERISTICS
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counted for 43% (n = 89). Students made up a relatively small fraction of the study group (n = 18, 9%). Patients diagnosed with eczema! dermatitis had the highest representation (36%) among participants, followed in decreasing order by patients with urticaria, atopic dermatitis (AD), pruritus, prurigo, and psoriasis (Table 5) . Table 6 shows the baseline work, classroom, and daily activity WPAI-AS productivity scores. Due to the relatively small sample size of each disease group, statistically significant differences in impairment between disease groups were not detected (Fig. 2) . However, the results indicate that the overall impairment of work, classroom, and daily activity productivity tended to be larger in the atopic dermatitis, eczema! dermatitis, and urticaria disease groups (Fig.  2 ). There were also some interesting group-specific observations. Prurigo showed higher overall impairment of work productivity and daily activity. Individuals with urticaria had relatively higher percentages of impairment of overall classroom productivity than that observed in other skin diseases. Daily activity was impaired at high percentages for individuals with AD.
ASSESSMENT OF WORK, CLASSROOM, AND ACTIVITY IMPAIRMENT
CORRELATION BETWEEN PRODUCTIVITY IM-PAIRMENT AND SKINDEX-16, OR LOSS OF DAILY LIFE PRODUCTIVITY
To check the validity of the assessment procedures in this study, we looked for correlations between impaired productivity at work, in the classroom, and in daily activities. In addition, correlations between overall activity impairment, the magnitude of itch sensation as assessed by VAS, and QOL measures as assessed by Skindex-16 were analyzed ( Table 1) . As shown in Table 1 , correlation analyses were divided between allergic (atopic dermatitis and urticaria) and non-allergic skin diseases (all other diagnosis groups). Results specific for allergic skin diseases indicated that impairment in overall work productivity showed a positive correlation with the itch VAS, Skindex-16, and the impairment in daily activity. A correlation between impairment in overall classroom Di f f e r e n c e s i n t h e d i s t r i b u t i o n o f p a t i e n t s b e t we e n s e d a t i v e a n d n o n -s e d a t i v e a n t i h i s t a me g r o u p s wa s d e t e r mi n e d b y t h e F i s h e r ' s e x a c t t e s t f o r a g e , g e n d e r , a n d d u r a t i o n o f d i s e a s e a n d b y t h e Co c h r a n -Ma n t e l -Ha e n s z e l g e n e r a l a s s o c i a t i o n s t a t i s t i c productivity and itch VAS, Skindex-16 score, and activity impairment was not observed for the allergic skin diseases (Table 1) . However, in the allergic skin disease subgroup there was a positive correlation between the impairment in daily activity and the magnitude of itch and Skindex-16 scores.
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Similar analyses were performed on the subgroup of patients with all other skin disease diagnoses except atopic dermatitis and urticaria. This group was designated the non-allergic skin disease group even though varying causative conditions including allergic and non-allergic mechanisms could be responsible for symptoms related to eczema! dermatitis. As shown in Table 1 , the correlation profile of this subgroup was very similar to that of the allergic skin disease subgroup with one major difference. There was a significant correlation between overall classroom productivity and activity impairment in the nonallergic skin disease subgroup (Table 1) .
IMPACT OF ANTIHISTAMINES ON PATIENT OUTCOMES
Patients were treated with non-sedative antihistamines (n = 74), sedative antihistamines (n = 121), or external medication (n = 11) for a duration of 1 month ( Table 7) . The patient characteristics in the physician-assigned treatment groups of sedative and non-sedative antihistamines were all well-matched with the exception of occupation (Table 3) . We previously reported that the impaired productivity in pruritic skin diseases was significantly improved in patients taking non-sedative antihistamines. 12 Interestingly, for patients taking non-sedative antihistamines in this study, the improvement ratio as assessed using the VAS score showed a significant correlation with improvements in the Skindex-16 score, the reduction in overall work productivity impairment, and the reduction in daily activity impairment. No significant correlations were found among patients taking sedative antihistamines (Table 2) .
To eliminate the bias for starting value dispersion, the effects of non-sedative and sedative antihistamines on overall work productivity, daily activity, and overall classroom productivity were corrected by grouping according to background factors or baseline value using the linear least-squares methods (Fig.  1A) . Results indicated that non-sedative antihistamines produced greater overall improvements in pro- 
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Ot h e r s P s o r i a s i s P r u r i g o P r u r i t u s Ur t i c a r i a E c / De rductivity in patients with skin diseases than sedative antihistamines (Fig. 1A) . Non-sedative antihistamines significantly improved work productivity under almost all background conditions with the exception of disease duration. Sedative antihistamines only had a significant impact on the subpopulation of patients that were male or those that had a diagnosis of eczema! dermatitis (Fig. 1A) .
The duration of disease was the only baseline patient characteristic that could significantly influence or bias the outcomes seen from administration of antihistamines (Table 4) . Therefore, we compared the amount of change in the overall work impairment in the sedative and non-sedative antihistamine treatment groups after adjusting for the baseline duration of disease (Fig. 1B) . These results confirmed that non-sedative antihistamines significantly improved the overall work impairment, while sedative antihistamines did not (Fig. 1B) . Evaluation of impact of antihistamines on daily activity impairment and overall classroom impairment also demonstrate the superiority of non-sedative antihistamines over sedative antihistamines (Fig. 1A) . Interestingly, sedative antihistamines failed to improve overall classroom productivity in all the patient population groups analyzed (Fig.  1A) .
THE EFFECT OF ANTIHISTAMINES ON ATOPIC DERMATITIS
The effect of antihistamines on atopic dermatitis is still controversial. 14,15 Therefore, the treatment effects specifically for patients with atopic dermatitis (n = 43) were analyzed independently from other diagnostic groups (Fig. 3) . As expected, treatment with antihistamines significantly reduced itch intensity in atopic dermatitis, while external medicines were ineffective (Fig. 3A) . No differences were found between patients taking non-sedative versus sedative antihistamines (Fig. 3A) . The impact of all treatments on the Skindex-16 QOL measure was similar to that for the itch VAS, with a significant effect for all antihistamines, but not for topical medications (Fig. 3B) . Both non-sedative, and sedative antihistamines improved overall work impairment without statistical significance (Fig. 3C) . Alternatively, the non-sedative antihistamine significantly reduced activity productivity impairment, whereas the trend towards improvement seen with sedative antihistamines did not reach statistical significance (Fig. 3D) . These patients were prescribed concomitant external medications, but there were no remarkable differences between the nonsedative and sedative antihistamines treatment groups (Fig. 3E) .
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DISCUSSION
This study demonstrates that allergic skin diseases may have detrimental effects on productivity at work, in the classroom, and during daily activity. Previous reports demonstrated that allergic rhinitis impaired mean overall productivity at work, in the classroom, and in daily activity by ratios of 27-48%, 33-47%, and 42-51%, respectively. [16] [17] [18] [19] In the present study, work performance and daily activities were highly and similarly impaired in patients with allergic skin diseases. However, WPAI-AS baseline scores in our study were slightly high relative to previous reports of WPAI (unidentified version) baseline scores for chronic idiopathic urticaria, psoriasis, and chronic hand dermatitis. 5, 6, 8 It is not currently clear why the present study generated different WPAI baseline scores, but further investigation is warranted.
According to the WPAI-AS values for the various pruritic skin diseases, the impairments in classroom productivity and overall classroom productivity were higher for patients with urticaria (Fig. 2) . To clarify the reason why urticaria affected classroom productivity, cases of students with urticaria were analyzed independently for correlations with certain parameters (data not shown). Only the Skindex-16 was significantly associated with classroom impairment in this group (P = 0.0075, r = 0.9282, n = 6). Presumably, urticaria may impair a student's classroom productivity by negatively impacting their QOL.
In previous reports, WAPI scores of overall work impairment in patients with psoriasis were lower than those for patients with chronic idiopathic urticaria and chronic hand dermatitis. 5, 6, 8 Pearce and colleagues 6 discussed the observation that QOL measures did not exhibit the same trend as WPAI score in F i g . 3 T h e i mp a c t o f a n t i h i s t a mi n e s o n ( A) i t c h V A S , ( B) s k i n d e x -1 6 s c o r e , ( C) o v e r a l l wo r k p r o d u c t i v i t y i mp a i r me n t , a n d ( D) d a i l y a c t i v i t y p r o d u c t i v i t y i mp a i r me n t i n a t o p i c d e r ma t i t i s . T h e d a t a o f b a s e l i n e a s s e s sme n t ( d a r k g r a y b a r ) a n d p o s t t r e a t me n t a s s e s s me n t ( l i g h t g r a y b a r ) a r e s h o wn a s me a n ± S D. * * S t a t i s t ic a l l y s i g n i f i c a n t i mp r o v e me n t c o mp a r e d wi t h t h e d a t a o f b a s e l i n e a s s e s s me n t ( P < 0 . 0 0 1 ) , * P < 0 . 0 1 . NA , n o t a p p l i c a b l e ; A H, a n t i h i s t a mi n e s . ( E ) Co n c o mi t a n t e x t e r n a l me d i c i n e f o r c a s e s wi t h a t o p i c d e r ma t i t i s . "Ot h e r "i n c l u d e s v i t a mi n D3 o r n o n -s t e r o i d a l a n t i -i n f l a mma t o r y o i n t me n t . patients with psoriasis, and indicated that estimating the impact of psoriasis on social life seemed to be difficult. Indeed, as the number of patients with psoriasis was low in this study, which may indicate that our data are not representative of the general population of patients with psoriasis. Concerning WPAI-AS scores in patients with atopic dermatitis, the total loss of daily activities was relatively higher than for patients with other skin diseases (Table 6, Fig. 2 ). It has been said that the intensity of itch might be increased in a relaxed environment, such as coming home or at nighttime. 20 In support of this, daily activity in patients with atopic dermatitis or pruritus was severely impaired compared with the impairment in overall work productivity (Table 6). Thus, daily activity may be highly susceptible to impairment in patients with atopic dermatitis and pruritus.
The differences between patients taking nonsedative versus sedative antihistamines was also addressed. As previously reported, sedative antihistamines failed to reduce work productivity impairment despite decreasing itch VAS values and Skindex-16 measures. 12 Impaired performance as an adverse effect of sedative antihistamines may be a major factor in these divergent results. In fact, in patients treated with sedative antihistamines, the improvement ratio for itch VAS scores did not significantly correlate with either the Skindex-16 QOL measure, the reduced impairment in overall work productivity, or the reduced impairment in daily activity (Table 2) . Additionally, the extent of impairment in overall work productivity can be predicted by the Skindex-16 measures (Table 1 ). Nevertheless, clinicians should keep in mind that they could overestimate the effect of sedative antihistamines to improve on work productivity by relying solely on patient itch-intensity and QOL values. For these reasons, non-sedative antihistamines have substantial value in the treatment of patients with pruritic skin diseases.
However, the criteria for selecting antihistamines differ from disease to disease and vary worldwide. It is well known that non-sedative antihistamines, but not sedative antihistamines, are recommended as first-line agents for urticaria treatment. [21] [22] [23] [24] [25] In contrast, many previous published reviews, guidelines, and position papers on the care of atopic dermatitis state that the antihistamines are no more than a supportive management for pruritus, and their sedative properties offer an advantage for reducing the magnitude of itch in atopic dermatitis. 14, 15, 26, 27 Thus, there is a tendency worldwide to recommend sedative antihistamines for the treatment of atopic dermatitis with intense itch or sleep disturbance. 14, 15, 26 Our data challenge this trend, since non-sedative antihistamines reduced the impairments in daily activity in patients with atopic dermatitis, while sedative antihistamines were ineffective (Fig. 1A, 3) . Accordingly, the criteria for selecting antihistamines in certain skin diseases should be reconsidered.
Limitations of this study include the number of patients in each group and the potential influences of the adverse global economic conditions. Nonetheless, this report may highlight a new goal in the treatment of pruritic skin diseases and provide a rationale for shifting the choice of treatment options to nonsedative antihistamines.
